Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APLT |
---|---|---|
09:32 ET | 6255 | 4.315 |
09:34 ET | 300 | 4.32 |
09:36 ET | 300 | 4.31 |
09:38 ET | 200 | 4.31 |
09:39 ET | 300 | 4.31 |
09:41 ET | 200 | 4.31 |
09:43 ET | 400 | 4.31 |
09:45 ET | 2194 | 4.3234 |
09:48 ET | 7552 | 4.3499 |
09:50 ET | 458 | 4.335 |
09:52 ET | 3053 | 4.33 |
09:56 ET | 800 | 4.315 |
09:57 ET | 1516 | 4.32 |
10:06 ET | 961 | 4.315 |
10:08 ET | 100 | 4.31 |
10:15 ET | 1531 | 4.32 |
10:17 ET | 100 | 4.33 |
10:19 ET | 400 | 4.34 |
10:21 ET | 1432 | 4.33 |
10:26 ET | 2000 | 4.3399 |
10:30 ET | 500 | 4.33 |
10:33 ET | 1958 | 4.34 |
10:37 ET | 1031 | 4.335 |
10:39 ET | 6827 | 4.33 |
10:42 ET | 917 | 4.345 |
10:44 ET | 4200 | 4.35 |
10:46 ET | 1800 | 4.345 |
10:48 ET | 700 | 4.35 |
10:50 ET | 6711 | 4.39 |
10:51 ET | 3523 | 4.39 |
10:53 ET | 6538 | 4.39 |
10:55 ET | 7803 | 4.395 |
10:57 ET | 5900 | 4.395 |
11:00 ET | 4773 | 4.39 |
11:02 ET | 2300 | 4.365 |
11:04 ET | 1212 | 4.385 |
11:06 ET | 700 | 4.385 |
11:08 ET | 1000 | 4.3811 |
11:09 ET | 1200 | 4.4 |
11:11 ET | 300 | 4.4 |
11:13 ET | 529 | 4.3917 |
11:15 ET | 200 | 4.395 |
11:18 ET | 11317 | 4.43 |
11:20 ET | 300 | 4.43 |
11:22 ET | 200 | 4.43 |
11:24 ET | 2402 | 4.42 |
11:26 ET | 473 | 4.425 |
11:27 ET | 482 | 4.425 |
11:29 ET | 3550 | 4.41 |
11:33 ET | 100 | 4.42 |
11:36 ET | 300 | 4.415 |
11:38 ET | 1080 | 4.42 |
11:40 ET | 200 | 4.42 |
11:42 ET | 975 | 4.43 |
11:44 ET | 1323 | 4.43 |
11:45 ET | 2125 | 4.425 |
11:47 ET | 1864 | 4.43 |
11:49 ET | 6539 | 4.43 |
11:51 ET | 2144 | 4.43 |
11:54 ET | 550 | 4.43 |
11:56 ET | 28453 | 4.435 |
11:58 ET | 2505 | 4.41 |
12:00 ET | 200 | 4.42 |
12:02 ET | 2069 | 4.405 |
12:03 ET | 511 | 4.41 |
12:05 ET | 864 | 4.4 |
12:07 ET | 300 | 4.41 |
12:09 ET | 1074 | 4.41 |
12:12 ET | 300 | 4.41 |
12:14 ET | 500 | 4.4 |
12:16 ET | 5706 | 4.395 |
12:18 ET | 527 | 4.4 |
12:20 ET | 5707 | 4.405 |
12:21 ET | 800 | 4.405 |
12:23 ET | 800 | 4.41 |
12:25 ET | 7788 | 4.43 |
12:27 ET | 5572 | 4.41 |
12:30 ET | 1200 | 4.4 |
12:32 ET | 2454 | 4.39 |
12:36 ET | 400 | 4.395 |
12:38 ET | 910 | 4.405 |
12:39 ET | 931 | 4.39 |
12:41 ET | 216 | 4.4 |
12:43 ET | 100 | 4.39 |
12:45 ET | 200 | 4.39 |
12:48 ET | 3117 | 4.37 |
12:50 ET | 200 | 4.39 |
12:52 ET | 300 | 4.39 |
12:54 ET | 900 | 4.39 |
12:56 ET | 100 | 4.39 |
12:57 ET | 100 | 4.4 |
12:59 ET | 500 | 4.4 |
01:01 ET | 26308 | 4.41 |
01:03 ET | 600 | 4.41 |
01:06 ET | 90996 | 4.41 |
01:08 ET | 3665 | 4.41 |
01:10 ET | 2313 | 4.4 |
01:14 ET | 100 | 4.4 |
01:15 ET | 3314 | 4.415 |
01:17 ET | 400 | 4.43 |
01:19 ET | 1200 | 4.42 |
01:21 ET | 800 | 4.44 |
01:24 ET | 300 | 4.45 |
01:26 ET | 1500 | 4.47 |
01:28 ET | 3393 | 4.47 |
01:30 ET | 200 | 4.46 |
01:32 ET | 3900 | 4.465 |
01:33 ET | 996 | 4.46 |
01:35 ET | 300 | 4.4629 |
01:37 ET | 437 | 4.47 |
01:39 ET | 1045 | 4.4614 |
01:42 ET | 400 | 4.47 |
01:44 ET | 3504 | 4.47 |
01:46 ET | 200 | 4.47 |
01:48 ET | 3057 | 4.455 |
01:50 ET | 3844 | 4.455 |
01:53 ET | 1288 | 4.46 |
01:55 ET | 1932 | 4.455 |
01:57 ET | 100 | 4.455 |
02:00 ET | 200 | 4.45 |
02:04 ET | 100 | 4.45 |
02:06 ET | 6047 | 4.43 |
02:08 ET | 4150 | 4.43 |
02:09 ET | 100 | 4.44 |
02:11 ET | 6084 | 4.45 |
02:13 ET | 100 | 4.44 |
02:15 ET | 500 | 4.45 |
02:18 ET | 1800 | 4.45 |
02:20 ET | 400 | 4.45 |
02:22 ET | 6101 | 4.43 |
02:24 ET | 100 | 4.43 |
02:26 ET | 500 | 4.43 |
02:27 ET | 400 | 4.43 |
02:29 ET | 200 | 4.42 |
02:31 ET | 200 | 4.43 |
02:33 ET | 2664 | 4.425 |
02:36 ET | 300 | 4.43 |
02:38 ET | 3975 | 4.415 |
02:40 ET | 800 | 4.415 |
02:42 ET | 699 | 4.415 |
02:44 ET | 3730 | 4.4 |
02:45 ET | 100 | 4.4 |
02:47 ET | 100 | 4.4 |
02:51 ET | 100 | 4.4 |
02:54 ET | 500 | 4.41 |
02:56 ET | 3359 | 4.41 |
02:58 ET | 1400 | 4.41 |
03:00 ET | 3798 | 4.39 |
03:02 ET | 607 | 4.39 |
03:03 ET | 2300 | 4.39 |
03:05 ET | 3462 | 4.41 |
03:07 ET | 1700 | 4.41 |
03:09 ET | 2600 | 4.41 |
03:12 ET | 2993 | 4.41 |
03:14 ET | 4323 | 4.415 |
03:16 ET | 600 | 4.415 |
03:18 ET | 600 | 4.41 |
03:20 ET | 1078 | 4.415 |
03:21 ET | 10098 | 4.395 |
03:23 ET | 4282 | 4.395 |
03:25 ET | 1593 | 4.395 |
03:27 ET | 4567 | 4.39 |
03:32 ET | 5853 | 4.4 |
03:34 ET | 900 | 4.395 |
03:36 ET | 900 | 4.4 |
03:38 ET | 23753 | 4.395 |
03:39 ET | 14506 | 4.42 |
03:41 ET | 3421 | 4.43 |
03:43 ET | 500 | 4.44 |
03:45 ET | 4187 | 4.46 |
03:48 ET | 7387 | 4.46 |
03:50 ET | 1393 | 4.47 |
03:52 ET | 2797 | 4.47 |
03:54 ET | 700 | 4.49 |
03:56 ET | 9556 | 4.495 |
03:57 ET | 24143 | 4.49 |
03:59 ET | 37352 | 4.51 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Applied Therapeutics Inc | 515.3M | -2.4x | --- |
Iteos Therapeutics Inc | 506.3M | -3.7x | --- |
Northwest Biotherapeutics Inc | 520.7M | -6.8x | --- |
Annexon Inc | 464.6M | -3.1x | --- |
Kalvista Pharmaceuticals Inc | 497.4M | -3.8x | --- |
Astria Therapeutics Inc | 498.6M | -3.9x | --- |
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare metabolic diseases, including Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency, and PMM2-CDG. The Company is also developing AT-001, a novel potent ARI, for the treatment of Diabetic Cardiomyopathy (DbCM) a fatal fibrosis of the heart. It has completed a Phase I/II clinical trial evaluating AT-001 in approximately 120 patients with type 2 diabetes, in which no drug-related adverse effects or tolerability issues were observed. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of Diabetic retinopathy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $515.3M |
---|---|
Revenue (TTM) | $-477.0K |
Shares Outstanding | 114.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.99 |
EPS | $-1.91 |
Book Value | $-0.20 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.